This document provides guidance to industry on practical aspects of the implementation of the Agency's policy on the publication of clinical data for medicinal products for human use. It covers guidance on the procedural aspects of the submission of clinical reports, the anonymisation of clinical reports and the identification and redaction of commercially confidential information in clinical reports. This guidance is revised periodically, with the most recent update in May 2025.
Keywords: Clinical data publication, anonymisation of clinical reports, commercially confidential information (CCI), policy 0070, redaction proposals